Home
>
National Drug Code (NDC)
>
Sonata
Sonata - 54868-5139-0 - (zaleplon)
Drug Information of Sonata
| Product NDC: | 54868-5139 |
| Proprietary Name: | Sonata |
| Non Proprietary Name: | zaleplon |
| Active Ingredient(s): | 5 mg/1 & nbsp; zaleplon |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sonata
| Product NDC: | 54868-5139 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020859 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070905 |
Package Information of Sonata
| Package NDC: | 54868-5139-0 |
| Package Description: | 10 CAPSULE in 1 BOTTLE (54868-5139-0) |
NDC Information of Sonata
| NDC Code | 54868-5139-0 |
| Proprietary Name | Sonata |
| Package Description | 10 CAPSULE in 1 BOTTLE (54868-5139-0) |
| Product NDC | 54868-5139 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zaleplon |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070905 |
| Marketing Category Name | NDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | ZALEPLON |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
